Transcriptomics

Dataset Information

0

Deferasirox, an iron chelator, impacts myeloid differentiation by modulating NF-kB activity via mitochondrial ROS


ABSTRACT: Deferasirox (DFX) can improve erythropoiesis in patients with MDS. We sought to test how these changes occur and whether myelopoiesis broadly is affected by analyzing neutrophils and neutrophil precursors treated with DFX.

ORGANISM(S): Homo sapiens

PROVIDER: GSE274956 | GEO | 2024/09/27

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2020-11-04 | GSE160727 | GEO
| PRJNA1148639 | ENA
2022-11-16 | GSE218133 | GEO
2018-12-04 | GSE123277 | GEO
| PRJNA902387 | ENA
2016-05-13 | GSE81363 | GEO
2016-05-13 | E-GEOD-81363 | biostudies-arrayexpress
2019-12-13 | GSE141958 | GEO
2019-09-02 | E-MTAB-6658 | biostudies-arrayexpress
| 2100588 | ecrin-mdr-crc